000 02428 a2200697 4500
005 20250517210647.0
264 0 _c20190729
008 201907s 0 0 eng d
022 _a2567-689X
024 7 _a10.1055/s-0038-1639586
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeetermans, Marijke
245 0 0 _aTargeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.
_h[electronic resource]
260 _bThrombosis and haemostasis
_c05 2018
300 _a818-829 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Intravenous
650 0 4 _aAdministration, Oral
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aAntithrombins
_xadministration & dosage
650 0 4 _aArginine
_xanalogs & derivatives
650 0 4 _aBacteremia
_xdiagnosis
650 0 4 _aBelgium
650 0 4 _aBlood Coagulation
_xdrug effects
650 0 4 _aCoagulase
_xantagonists & inhibitors
650 0 4 _aDabigatran
_xadministration & dosage
650 0 4 _aEnoxaparin
_xadministration & dosage
650 0 4 _aFeasibility Studies
650 0 4 _aFemale
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPartial Thromboplastin Time
650 0 4 _aPilot Projects
650 0 4 _aPipecolic Acids
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aStaphylococcal Infections
_xdiagnosis
650 0 4 _aStaphylococcus aureus
_xdrug effects
650 0 4 _aSulfonamides
650 0 4 _aThrombin
_xantagonists & inhibitors
650 0 4 _aThrombosis
_xblood
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aLiesenborghs, Laurens
700 1 _aPeerlinck, Kathelijne
700 1 _aWijngaerden, Eric Van
700 1 _aGheysens, Olivier
700 1 _aGoffin, Karolien E
700 1 _aHoylaerts, Marc F
700 1 _aJacquemin, Marc
700 1 _aVerhaegen, Jan
700 1 _aPeetermans, Willy E
700 1 _aVerhamme, Peter
700 1 _aVanassche, Thomas
773 0 _tThrombosis and haemostasis
_gvol. 118
_gno. 5
_gp. 818-829
856 4 0 _uhttps://doi.org/10.1055/s-0038-1639586
_zAvailable from publisher's website
999 _c28247426
_d28247426